General form of registration statement for all companies including face-amount certificate companies

Condensed Balance Sheets

v3.21.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Current assets:      
Cash $ 9,609,631 $ 13,953,513 $ 18,457
Grants receivable 332,774    
Prepaid research and development 712,674 774,356  
Prepaid expenses and other current assets 1,216,173 54,837 16,924
Total 11,871,252 14,782,706 35,381
Deferred initial public offering costs 2,783   2,873
Total assets 11,874,035 14,782,706 38,254
Current liabilities:      
Accounts payable 715,016 1,720,680 1,001,699
Accrued expenses and other current liabilities 627,399 632,934 1,724,141
Deferred revenue 1,251,349 2,325,741 1,428,636
Notes payable 994,789 42,534 98,419
Total 3,588,553 4,721,889 4,252,895
Notes payable, net of current portion 248,911 276,461 275,375
Total liabilities 3,837,464 4,998,350 4,528,270
Commitments and contingencies (see Note 10,11)
Stockholders' equity (deficit):      
Preferred stock, $0.001 par value; 10,000,000 and 0 shares authorized at December 31, 2020 and 2019; 0 shares issued and outstanding at December 31, 2020 and 2019
Common stock, $0.001 par value; 100,000,000 and 30,000,000 shares authorized; 10,050,849 and 8,180,937 shares issued and outstanding at December 31, 2020 and 2019 10,060 10,051 8,181
Additional paid-incapital 25,695,203 24,805,929 7,685,533
Accumulated deficit (17,668,692) (15,031,624) (12,183,730)
Total 8,036,571 9,784,356 (4,490,016)
Total liabilities and stockholders' equity $ 11,874,035 $ 14,782,706 $ 38,254